Jean Louis Frantz, Huang Jennifer Y, Nebie Yacouba K, Koivogui Lamine, Jayaraman Gayatri, Abiola Nadine, Vansteelandt Amanda, Worrel Mary C, Shang Judith, Murphy Louise B, Fitter David L, Marston Barbara J, Martel Lise
Centers for Disease Control and Prevention, Port-au-Prince, Haiti.
Centers for Diseases Control and Prevention, Atlanta, Georgia, United States.
Afr J Lab Med. 2017 Mar 31;6(1):484. doi: 10.4102/ajlm.v6i1.484. eCollection 2017.
Laboratory-enhanced surveillance is critical for rapidly detecting the potential re-emergence of Ebola virus disease. Rapid diagnostic tests (RDT) for Ebola antigens could expand diagnostic capacity for Ebola virus disease.
The Guinean National Coordination for Ebola Response conducted a pilot implementation to determine the feasibility of broad screening of patients and corpses with the OraQuick Ebola RDT.
The implementation team developed protocols and trained healthcare workers to screen patients and corpses in Forécariah prefecture, Guinea, from 15 October to 30 November 2015. Data collected included number of consultations, number of fevers reported or measured, number of tests performed for patients or corpses and results of confirmatory RT-PCR testing. Data on malaria RDT results were collected for comparison. Feedback from Ebola RDT users was collected informally during supervision visits and forums.
There were 3738 consultations at the 15 selected healthcare facilities; 74.6% of consultations were for febrile illness. Among 2787 eligible febrile patients, 2633 were tested for malaria and 1628 OraQuick Ebola RDTs were performed. A total of 322 OraQuick Ebola RDTs were conducted on corpses. All Ebola tests on eligible patients were negative.
Access to Ebola testing was expanded by the implementation of RDTs in an emergency situation. Feedback from Ebola RDT users and lessons learned will contribute to improving quality for RDT expansion.
实验室强化监测对于快速检测埃博拉病毒病的潜在再次出现至关重要。针对埃博拉抗原的快速诊断检测(RDT)可扩大埃博拉病毒病的诊断能力。
几内亚埃博拉应对国家协调机构进行了一项试点实施,以确定使用奥夸克埃博拉RDT对患者和尸体进行广泛筛查的可行性。
实施团队制定了方案,并培训医护人员于2015年10月15日至11月30日在几内亚福雷卡里亚地区对患者和尸体进行筛查。收集的数据包括咨询次数、报告或测量的发热人数、对患者或尸体进行的检测次数以及确诊逆转录聚合酶链反应(RT-PCR)检测结果。收集疟疾RDT结果数据用于比较。在监督访问和论坛期间非正式收集了埃博拉RDT使用者的反馈。
在15家选定的医疗机构进行了3738次咨询;74.6%的咨询是针对发热性疾病。在2787名符合条件的发热患者中,2633人接受了疟疾检测,1628次进行了奥夸克埃博拉RDT检测。共对322具尸体进行了奥夸克埃博拉RDT检测。对符合条件患者的所有埃博拉检测均为阴性。
在紧急情况下通过实施RDT扩大了埃博拉检测的可及性。埃博拉RDT使用者的反馈和经验教训将有助于提高RDT推广的质量。